The conversation around weight management is changing, and this time, it’s not driven by hype, social media trends, or extreme promises. In December 2025, Novo Nordisk  received U.S. FDA approval  for the first oral GLP-1–based weight-loss pill , a tablet version of its well-known injectable therapy, Wegovy. This marks a pivotal moment not only for pharmaceutical innovation, but for how people may finally access sustainable, medically supported weight loss. For years, injecta